Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Tomorrow # II

Precedent set with cheap prior licenses. Obviously the decision is great news but, what leverage do we have? Can the next prospective infringer argue about unreasonable licensing fees? I know HTC is considered low hanging fruit. I still find that number and the unwillful portion to be of concern regarding future leverage. Thanks again for all your work. Look forward to upcoming details from the company, otherwise I suspect the rise in s/p will be short lived as the traders and flippers take their cash.

Share
New Message
Please login to post a reply